Who owns Ariad Pharmaceuticals?

Key details on Ariad Pharmaceuticals (Ticker: ARIA)

Who owns Ariad Pharmaceuticals?

Is ARIA a good stock to own? Find out who bought Ariad Pharmaceuticals, who sold Ariad Pharmaceuticals (ARIA) stock, and who holds a large position in Ariad Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 13.38M $107.84M March 31, 2014
Sarissa Capital Management 12.00M $76.44M June 30, 2014
Vanguard 10.66M $67.88M June 30, 2014
GOLDMAN SACHS 8.46M $155.75M Sept. 30, 2013
Adage Capital Partners GP 6.67M $53.75M March 31, 2014
Slate Path Capital 6.62M $53.36M March 31, 2014
BlackRock Fund Advisors 6.44M $41.02M June 30, 2014
STATE STREET CORPORATION 5.77M $36.77M June 30, 2014
Waddell & Reed Financial 5.75M $105.87M Sept. 30, 2013
Ameriprise Financial 5.46M $100.41M Sept. 30, 2013
Neuberger Berman 5.44M $100.07M Sept. 30, 2013
Columbia Wanger Asset Management 5.29M $97.35M Sept. 30, 2013
Franklin Resources 5.04M $32.09M June 30, 2014
S.A.C. Capital Advisors 4.94M $119.62M Sept. 30, 2012
BlackRock Institutional Trust Company, N.A. 4.83M $30.76M June 30, 2014
T. Rowe Price Associates 4.77M $86.34M March 31, 2013
Damian Sousa 4.54M $84.80M Sept. 30, 2013
SUSQUEHANNA INTERNATIONAL 4.49M $36.21M March 31, 2014
Renaissance Technologies 4.40M $28.03M June 30, 2014
Janus Capital Management 4.20M $73.39M June 30, 2013
AQR Capital Management 3.88M $24.73M June 30, 2014
BB Biotech AG 3.69M $67.88M Sept. 30, 2013
TimesSquare Capital Management 3.59M $62.87M June 30, 2013
Federated Investors 3.47M $63.76M Sept. 30, 2013
Palo Alto Investors 3.46M $27.88M March 31, 2014
Perceptive Advisors 3.08M $37.70M Dec. 31, 2011
Sectoral Asset Management 3.01M $55.36M Sept. 30, 2013
Camber Capital Management 3.00M $24.18M March 31, 2014
Artisan Partners Limited Partnership 2.86M $52.58M Sept. 30, 2013
Third Point 2.75M $49.72M March 31, 2013
Barclays 2.74M $21.93M March 31, 2014
ALLIANCEBERNSTEIN 2.72M $46.89M June 30, 2012
Turner Investments 2.68M $64.85M Sept. 30, 2012
Oak Ridge Investments 2.64M $48.61M Sept. 30, 2013
Jennison Associates 2.34M $44.93M Dec. 31, 2012

Who sold Ariad Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
J P MORGAN CHASE & CO Dec. 31, 2010 2.52M $12.86M